Litcius/Paper detail

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial

Messoud Ashina, Michel Lantéri‐Minet, Patricia Pozo‐Rosich, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjørn Sperling

2022The Lancet Neurology160 citationsDOI

Topics & Concepts

MedicineMigrainePlaceboPhysical therapyPhase (matter)Double blindPhysical medicine and rehabilitationAlternative medicineAnesthesiaPathologyOrganic chemistryChemistryMigraine and Headache StudiesTraumatic Brain Injury and Neurovascular DisturbancesNeurological Complications and Syndromes